Last reviewed · How we verify
Breakthrough cancer pain
Approved treatments
- Fentanyl (F2) · Oslo University Hospital
- Duragesic · Johnson & Johnson (Janssen Pharmaceutica)
Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Breakthrough cancer pain patent landscape — cliff calendar, originator estates, attackable patents
- Breakthrough cancer pain treatment landscape brief
- Breakthrough cancer pain treatment updates RSS
Frequently asked questions about Breakthrough cancer pain
What drugs treat Breakthrough cancer pain?
Tracked treatments include Fentanyl (F2), Duragesic.
What is the treatment for Breakthrough cancer pain?
Standard treatment for Breakthrough cancer pain includes Fentanyl (F2), Duragesic. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Breakthrough cancer pain patent cliff · Breakthrough cancer pain CI report
- Treatment: Fentanyl (F2) · Oslo University Hospital
- Treatment: Duragesic · Johnson & Johnson (Janssen Pharmaceutica)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing